Intelligent Ultrasound Group PLC Directorate Change (9388V)
August 15 2022 - 2:00AM
UK Regulatory
TIDMIUG
RNS Number : 9388V
Intelligent Ultrasound Group PLC
15 August 2022
15 August 2022
Intelligent Ultrasound Group plc
("IUG" or the "Company")
Director changes
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to
clinic' ultrasound company, specialising in artificial intelligence
(AI) software and simulation, announces the appointment of
Christian Guttmann as a Non-executive Director to its Board of
Directors, effective from 15 August 2022. Concurrent with this
appointment, Andrew Barker, who has been a Non-executive Director
since 2017, has announced his intention to retire from the Board as
of 31 December 2022.
Dr Guttmann is a recognised leader in shaping the global agenda
on AI regulation and standards, as well as having outstanding AI
research, development and AI commercialisation experience. He has
edited and authored seven books, over 50 publications and has three
patents in the field of AI.
Christian is currently an Executive Director of the Nordic
Artificial Intelligence Institute (NAII) and Vice President and
Global Head of Artificial Intelligence and Data at TietoEVRY in
Sweden. He has built over 100 novel AI systems and products and has
been an organiser / steering committee member at major AI
conferences. As a founder of the Nordic AI Institute, he advises
governments, thinktanks and businesses around the world.
Christian will join the Audit and Risk Committee, effective with
his appointment. Andrew will continue as Chair of the Remuneration
Committee until 31 December 2022, after which Michele Lesieur will
take over Chair of the committee.
Riccardo Pigliucci, Chairman of Intelligent Ultrasound said: "I
am delighted that Christian has agreed to join Intelligent
Ultrasound as a Non-executive Director. He was an outstanding
candidate for the position and his expertise and passion for
shaping the future of AI will be a major benefit to the Company as
we continue to expand our classroom to the clinic ultrasound
business. Christian's vast experience and knowledge of the industry
is second to none, and his credentials speak for themselves. He
will be an invaluable asset to our Board and we look forward to
capitalising on his skillset.
"Separately, I also would like to thank Andrew for his
invaluable contribution for the past five years and wish him
continued success in his personal and business endeavours."
The following details in relation to the appointment of
Christian Guttmann, aged 46, are disclosed in accordance with
Schedule 2(g) of the AIM Rules:
Current directorships Directorships held within the
last five years
Nordic Artificial Intelligence Health Essentials Nordic AB
Institute AB Nordic AI Institute AB
------------------------------
For further information, please contact:
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900
and Broker
Giles Balleny / Max Gould (Corporate
Finance)
Dale Bellis / Julian Morse (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy Mob: +44 (0)7876 741 001
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading
'classroom to clinic' ultrasound companies, specialising in
real-time hi-fidelity virtual reality simulation for the ultrasound
training market ('classroom') and artificial intelligence-based
clinical image analysis software tools for the diagnostic medical
ultrasound market ('clinic'). Based in Cardiff in the UK and
Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through
simulation. Our main products are the ScanTrainer obstetrics and
gynaecology training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care and Emergency
Medicine training simulator with Covid-19 module and the new
BabyWorks Neonate and Paediatric training simulator. To date over
1,400 simulators have been sold to c. 700 medical institutions
around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines
smarter and more accessible using our proprietary ScanNav
ultrasound image analysis technology. Current products on the
market utilising this technology are GE Healthcare's SonoLyst
software that is incorporated in their Voluson Expert 22 and SWIFT
ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time
AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved, but not yet available
for sale in the US or any other territory requiring government
approval for this type of product.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGPUPARUPPGBC
(END) Dow Jones Newswires
August 15, 2022 02:00 ET (06:00 GMT)
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Dec 2024 to Jan 2025
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Jan 2024 to Jan 2025
